ForthcomingEU Funding & Tenders portal
Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes
European Commission · Horizon Europe Framework Programme (HORIZON)
Expected Outcome: Proposals under this topic should aim to deliver results that are directed and tailored towards, and contribute to all of the following expected outcomes: Patients with rare or very rare cancers or…
- Clinical Research
- Common Cancers
- High Income Countries
- Oncology Nurses
- Precision Oncology
21 Sept 2027
About 12 months left
€3,000,000 – €10M per grant